Keywords
autoimmune diseases
hyhipergammaglobulinemia
therapy
How to Cite
Abstract
Autoimmune pancreatitis is a chronic inflammatory disease of unknown etiology, which affects mainly adults between 50 and 70 years old. It is characterized by presenting obstructive jaundice and hypergammaglobulinemia (IgG4). The diagnosis is suspected due to clinical characteristic findings and is confirmed by imaging criteria and specific serologies. It can be classified into two subtypes, type 1 and type 2 autoimmune pancreatitis, according to the histological pattern and associated clinical presentation. Treatment is based on steroids, and comprises two stages, induction of remission and maintenance, it has a good prognosis if it responds to treatment.
References
Ennazk L, Mghari GE, Ansari NE. Association of newly diagnosed type 1 diabetes and autoimmune pancreatitis. Endocrinol Diabetes Metab Case Rep. 2016;2016:16-0047. doi: 10.1530/EDM-16-0047.
Chatterjee S, Oppong KW, Scott JS, Jones DE, Charnley RM, Manas DM, et al. Autoimmune Pancreatitis-Diagnosis, Management and Longterm Follow-up. J Gastrointestin Liver Dis. 2014;23(2):179-185. doi: 10.15403/jgld.2014.1121.232.sc1
Shimosegawa T, Chari S, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011;40(3):352-358. doi: 10.1097/MPA.0b013e3182142fd2.
Salem A, Hamouda D, Parian A. Review Article: Diagnosis and Management of Igg4 Autoimmune Pancreatitis. J Pancreas. 2015;16(4):326-334. Disponible en: https://pancreas.imedpub.com/review-article-diagnosis-and-management-of-igg4-autoimmune-pancreatitis.pdf
Yan T, Ke Y, Chen Y, Xu C, Yu C, Li Y. Serological characteristics of autoimmune pancreatitis and its differential diagnosis from pancreatic cancer by using a combination of carbohydrate antigen 19-9, globulin, eosinophils and hemoglobin. PLoS ONE. 2017;12(4): e0174735. doi: 10.1371/journal.pone.0174735.
Cai O, Tan S. From pathogenesis, clinical manifestation, and diagnosis to treatment: an overview on autoimmune pancreatitis. Gastroenterol Res Pract. 2017;2017:3246459. doi: 10.1155/2017/3246459.
Hart P, Zen Y, Chari S. Recent advances in autoimmune pancreatitis. Gastroenterology. 2015;149(1):39-51. doi: 10.1053/j.gastro.2015.03.010.
O’Reilly D, Malde D, Duncan T, Rao M, Filobbos R. Review of the diagnosis, classification and management of autoimmune pancreatitis. World J Gastrointest Pathophysiol. 2014;5(2):71-81. doi: 10.4291/wjgp.v5.i2.71.
Gómez ÁA, Sánchez CE, Gutiérrez JM, Fernández Ávila DG, Mallarino C, Beltrán A, et al. Autoimmune pancreatitis. Rev Colomb Reumatol. 2014;21(1):46-50. doi: 10.1016/S0121-8123(14)70147-1
Dai C, Cao Q, Jiang M, Sun M. Serum immunoglobulin G4 in discriminating autoimmune pancreatitis from pancreatic cancer: a diagnostic meta-analysis. Pancreas. 2018;47(3):280-284. doi: 10.1097/mpa.0000000000000994
Lian M, Liu S, Wu G, Liu S. Serum IgG4 and IgG for the diagnosis of autoimmune pancreatitis: A systematic review with meta-analysis. Clin Res Hepatol Gastroenterol. 2015;40(1):90-109. doi: 10.1016/j.clinre.2015.06.002
Fritz S, Bergmann F, Grenacher L, Sgroi M, Hinz U, Hackert T, et al. Diagnosis and treatment of autoimmune pancreatitis types 1 and 2. Br J Surg. 2014;101(10):1257-1265. doi: 10.1002/bjs.9574
Rana S, Gupta R, Nada R, Gupta P, Basher R, Mittal B, et al. Clinical profile and treatment outcomes in autoimmune pancreatitis: a report from North India. Ann Gastroenterol. 2018;31(4):506-512. doi: 10.20524/aog.2018.0267
Senosiain Lalastra C, Foruny Olcina JR. Pancreatitis autoinmune. Gastroenterol Hepatol. 2015;38(9):549-555. doi: 10.1016/j.gastrohep.2015.01.006
Okazaki K, Chari S, Frulloni L, Lerch M, Kamisawa T, Kawa S, et al. International consensus for the treatment of autoimmune pancreatitis. Pancreatology. 2017;17(1):1-6. doi: 10.1016/j.pan.2016.12.003
Donet J, Czul F, Peña N, Barkin J. Type 1 autoimmune pancreatitis: case scenario and review of the disease. Rev Gastroenterol Peru. 2016;36(3):252-255. Disponible en: http://www.scielo.org.pe/pdf/rgp/v36n3/a10v36n3.pdf
Su Q, Zhang X, Zhang C, Hou Y, Yao Y, Cao B. Risk of Immune-Related Pancreatitis in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors: Systematic Assessment with Meta-Analysis. J Immunol Res. 2018;2018:1027323. doi: 10.1155/2018/1027323
Dehghani L, Mikail N, Kramkimel N, Soyer P, Lebtahi R, Mallone R, et al. Autoimmune pancreatitis after nivolumab anti–programmed death receptor-1 treatment. Eur J Cancer. 2018;104:243-246. doi: 10.1016/j.ejca.2018.09.014
Kolasinski N, Johannsen M, Hollon J. Fifteen-Year-Old Male with Type 2 Autoimmune Pancreatitis: An Argument for Endoscopy. Case Rep Gastroenterol. 2017;11(2):329-334. doi: 10.1159/000453659
Maruyama M, Watanabe T, Kanai K, Oguchi T, Asano J, Ito T, et al. Autoimmune pancreatitis can develop into chronic pancreatitis. Orphanet J Rare Dis. 2014;9(1):77-89. doi: 10.1186/1750-1172-9-77
Kitano Y, Imazawa M, Suzuki Y, Yamakita K, Iwamoto H, Takahashi K, et al. Our second autopsy case of autoimmune pancreatitis: A case report. Ann Gastroenterol Dig Syst. 2018;2(1):1010. Disponible en: https://meddocsonline.org/annals-of-gastroenterology-and-the-digestive-system/our-second-autopsy-case-of-autoimmune-pancreatitis-a-case-report.pdf
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright (c) 2020 Karolina González Houdelath, Natalia Salazar Campos, Luis Daniel Espinosa Sánchez, Iris Brenes Cubero, William Piedra Carvajal